ARA
American Renal Associates
–
Index: NYSE; Sector: Healthcare; Industry: Healthcare Facilities;
Marketcap: 237.76M; Volume: 30.84K; AvgVol 3m: 63.21K; Beta: 1.62;
Cost estimate:
P/E: –; EPS: -0.33; EPS growth quarter/prev quarter: 104.60%;
EPS growth this year: 31.10%; EPS growth past 5 years: -26.50%;
EPS ttm: -0.33;
P/S: 0.30; P/B: ; P/Cashflow: 1.86; P/FCF: 1.52;
Sales: 815.84M; Sales growth quarter/prev quarter: -3.80%; Sales growth past 5 years: 8.00%;
Profitability:
Gross Margin: 25.20%; Profit Margin: -1.30%; Operating Margin: 7.40%;
ROA – return on assets: -0.90%; ROE – return on equity: 13.20%; LT Debt/Equity: ; Total Debt/Equity: ;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 5.80%; Insider Transactions:0.00%;
Institutional Ownership: 82.40%; Institutional Transactions: -3.10%;
Data update: 07/10/2020.